Glaukos Financial Statements From 2010 to 2025
| GKOS Stock | USD 94.82 2.67 2.74% |
Check Glaukos Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Glaukos Corp's main balance sheet or income statement drivers, such as , as well as many indicators such as . Glaukos financial statements analysis is a perfect complement when working with Glaukos Corp Valuation or Volatility modules.
Check out the analysis of Glaukos Corp Correlation against competitors. Glaukos Corp Company Profit Margin Analysis
Glaukos Corp's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Glaukos Corp Profit Margin | (0.31) % |
Most of Glaukos Corp's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Glaukos Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Glaukos Corp has a Profit Margin of -0.3057%. This is 97.27% lower than that of the Health Care Equipment & Supplies sector and 94.4% lower than that of the Health Care industry. The profit margin for all United States stocks is 75.93% lower than that of the firm.
Glaukos Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Glaukos Corp's current stock value. Our valuation model uses many indicators to compare Glaukos Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Glaukos Corp competition to find correlations between indicators driving Glaukos Corp's intrinsic value. More Info.Glaukos Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Glaukos Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Glaukos Corp Financial Statements
Glaukos Corp shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Glaukos Corp investors may analyze each financial statement separately, they are all interrelated. The changes in Glaukos Corp's assets and liabilities, for example, are also reflected in the revenues and expenses on on Glaukos Corp's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California. Glaukos Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 727 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Glaukos Stock Analysis
When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.